LncRNA CALML3-AS1 modulated by m6A modification induces BTNL9 methylation to drive non-small-cell lung cancer progression

LncRNA JPX targets SERCA2a to mitigate myocardial ischemia/reperfusion injury by binding to EZH2

(2023) Jieli Bao et al.   EXPERIMENTAL CELL RESEARCH

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

m6A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer

(2022) Kazuo Tsuchiya et al.   CANCER GENE THERAPY

Complex cross-talk between EZH2 and miRNAs confers hallmark characteristics and shapes the tumor microenvironment

(2022) Christopher RT Hillyar et al.   Epigenomics

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update

(2022) Joanna Kapeleris et al.   Frontiers in Oncology

LINC00313 facilitates osteosarcoma carcinogenesis and metastasis through enhancing EZH2 mRNA stability and EZH2-mediated silence of PTEN expression

(2022) Chun-Yang Xing et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC

(2022) Qin Yang et al.   Frontiers in Genetics

LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside

(2022) Qin Hu et al.   Cell Death Discovery

lncRNA HOTTIP Recruits EZH2 to Inhibit PTEN Expression and Participates in IM Resistance in Chronic Myeloid Leukemia

(2022) Jing Liu et al.   Stem Cells International

The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1

(2022) Wenyi Shen et al.   Cancer Cell International

Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets

(2022) Mehrdad Hashemi et al.   PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY

Role of Long Noncoding RNAs in the Regulation of Cellular Immune Response and Inflammatory Diseases

(2022) Fen Feng et al.   Cells

Gene amplification-driven lncRNA SNHG6 promotes tumorigenesis via epigenetically suppressing p27 expression and regulating cell cycle in non–small cell lung cancer

(2022) Qi Wang et al.   Cell Death Discovery

Nuclear export protein CSE1L interacts with P65 and promotes NSCLC growth via NF-κB/MAPK pathway

(2021) Hechun Lin et al.   Molecular Therapy-Oncolytics

BTNL9 is frequently downregulated and inhibits proliferation and metastasis via the P53/CDC25C and P53/GADD45 pathways in breast cancer

(2021) Qingfan Mo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Targeting SLC3A2 subunit of system XC− is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma

(2021) Lifang Ma et al.   FREE RADICAL BIOLOGY AND MEDICINE

The detection and functions of RNA modification m6A based on m6A writers and erasers

(2021) Wei Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer

(2021) Zhenchuan Liu et al.   Molecular Cancer

Differential expression of long non-coding RNAs as diagnostic markers for lung cancer and other malignant tumors

(2021) Li Li et al.   Aging-US

Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma

(2021) Weishuang Ma et al.   BMC CANCER

ALKBH5-mediated m6A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma

(2020) Shuo Chen et al.   Cancer Cell International

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner

(2020) Xingya Guo et al.   Molecular Cancer

The potential role of RNA N6-methyladenosine in Cancer progression

(2020) Tianyi Wang et al.   Molecular Cancer

The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function

(2020) Lifang Ma et al.   Redox Biology

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression

(2019) Yi Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The role of m6A RNA methylation in cancer

(2019) Ting Sun et al.   BIOMEDICINE & PHARMACOTHERAPY

Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma

(2019) Zhongming Jiang et al.   MEDICAL SCIENCE MONITOR

Silencing of Long Non-coding RNA HOTTIP Reduces Inflammation in Rheumatoid Arthritis by Demethylation of SFRP1

(2019) Xumin Hu et al.   Molecular Therapy-Nucleic Acids

YTH Domain: A Family of N 6 -methyladenosine (m 6 A) Readers

(2018) Shanhui Liao et al.   GENOMICS PROTEOMICS & BIOINFORMATICS

LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316

(2018) Feng Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness

(2018) Daisy Melandri et al.   NATURE IMMUNOLOGY

Recent advances in dynamic m6A RNA modification

(2016) Guangchao Cao et al.   Open Biology

Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis

(2013) Christopher A. Koczor et al.   PHYSIOLOGICAL GENOMICS

ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility

(2012) Guanqun Zheng et al.   MOLECULAR CELL